SKIN Collar Strategy
SKIN (SkinHealth Systems Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
SKIN (SkinHealth Systems Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $83.8M, a beta of 1.07 versus the broader market, a 52-week range of 0.551-2.69, average daily share volume of 2.1M, a public-listing history dating back to 2020, approximately 613 full-time employees. These structural characteristics shape how SKIN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.07 places SKIN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a collar on SKIN?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
SKIN snapshot
As of August 14, 2026, spot at $0.67, ATM IV 86.40%, IV rank 25.09%, expected move 24.77%. The collar on SKIN below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this collar structure on SKIN specifically: IV regime affects collar pricing on both sides; compressed SKIN IV at 86.40% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 24.77% (roughly $0.17 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SKIN expiries trade a higher absolute premium for lower per-day decay. Position sizing on SKIN should anchor to the underlying notional of $0.67 per share and to the trader's directional view on SKIN stock.
SKIN collar setup
The SKIN collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SKIN at $0.67 on that close, the first option leg uses a $0.70 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SKIN chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SKIN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $0.67 | long |
| Sell 1 | Call | $0.70 | N/A |
| Buy 1 | Put | $0.64 | N/A |
SKIN collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
SKIN collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on SKIN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on SKIN
Collars on SKIN hedge an existing long SKIN stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
SKIN thesis for this collar
The market-implied 1-standard-deviation range for SKIN extends from approximately $0.50 on the downside to $0.84 on the upside. A SKIN collar hedges an existing long SKIN position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current SKIN IV rank near 25.09% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SKIN at 86.40%. As a Healthcare name, SKIN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SKIN-specific events.
SKIN collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SKIN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SKIN alongside the broader basket even when SKIN-specific fundamentals are unchanged. Always rebuild the position from current SKIN chain quotes before placing a trade.
Frequently asked questions
- What is a collar on SKIN?
- A collar on SKIN is the collar strategy applied to SKIN (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With SKIN stock at $0.67 on the most recent close, the strikes shown on this page are snapped to the nearest listed SKIN chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are SKIN collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the SKIN collar priced from the end-of-day chain at a 30-day expiry (ATM IV 86.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SKIN collar?
- The breakeven for the SKIN collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The SKIN market-implied 1-standard-deviation expected move in the same options snapshot is approximately 24.77%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on SKIN?
- Collars on SKIN hedge an existing long SKIN stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current SKIN implied volatility affect this collar?
- SKIN ATM IV is at 86.40% with IV rank near 25.09%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.